Previous close | 0.0500 |
Open | 0.0300 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 2.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0300 - 0.0300 |
Contract range | N/A |
Volume | |
Open interest | 37 |
Improved Financial Metrics and Strategic Partnerships Mark the Quarter
While the top- and bottom-line numbers for Heron Therapeutics (HRTX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 75% and 6.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?